Search for: "Novartis Pharmaceuticals Corporation"
Results 121 - 140
of 216
Sort by Relevance
|
Sort by Date
15 Feb 2011, 4:06 am
Unlike conventional retail sales, the patient is not at liberty to choose personally which prescription pharmaceutical he desires. [read post]
9 Feb 2011, 8:02 pm
Novartis, a federal jury in New York ordered Novartis Pharmaceutical, Inc. to pay over $250 million in damages, including punitive damages, to current and former female Novartis employees who brought claims of gender discrimination, including FRD. [read post]
27 Jan 2011, 8:22 am
Novartis got hit for $422.5 million for illegally marketing products. [read post]
27 Jan 2011, 8:22 am
Novartis got hit for $422.5 million for illegally marketing products. [read post]
5 Jan 2011, 9:22 am
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010. [read post]
23 Nov 2010, 2:00 pm
The largest fiscal year 2010 False Claims Act recoveries came from the pharmaceutical and medical device industries, which accounted for $1.6 billion in settlements, including the $669 million from Pfizer Inc., $302 million from AstraZeneca, and $192.7 from Novartis Pharmaceutical Corporation. [read post]
17 Nov 2010, 3:48 pm
On March 20, 2009, after "much pain and intense suffering and massive infection," Plaintiff had the Device removed.[4] [Plaintiff's Complaint, Doc. 1-1, ¶ IX, at 7].Plaintiff has filed product liability claims against Boston Scientific and Advanced Bionics, the corporations which allegedly "designed, manufactured, assembled, distributed and sold" the Device. [read post]
29 Oct 2010, 4:32 pm
9/1/2010 - Off-label marketing practices involving Botox AstraZeneca - $520 M- 4/27/2010 - Illegal marketing - anti-psychotic drug Seroquel Novartis Pharmaceuticals $422.5 million ($237.5 M - Civil allegations and a $185 M criminal fine) 9/30/2010 Unapproved promotion of Trileptal Forest Laboratories - $313 M - ($149M -Civil claims, a $150M criminal fine, and $14 M… [read post]
5 Oct 2010, 8:48 am
Department of Justice announced that it had reached an agreement with Novartis Pharmaceuticals Corporation in which the company agreed to pay $237.5 million to settle four False Claims Act lawsuits alleging that Novartis engaged in an unlawful off-label marketing scheme in connection with its anti-epileptic drug Trileptal and wrongfully paid kickbacks to physicians to encourage them to prescribe Trileptal, as well as other Novartis drugs. [read post]
4 Oct 2010, 4:35 pm
According to US prosecutors, Novartis Pharmaceuticals Corporation, which is the American subsidiary of Novartis AG of Switzerland, will have to pay criminal fines and forfeitures of $185 million, and more than $237 million to settle civil liabilities arising from its off label marketing. [read post]
1 Oct 2010, 4:51 pm
Department of Justice press release, “Novartis Pharmaceuticals Corporation to Pay $422.5 Million for Off-Label Drug Marketing. [read post]
1 Oct 2010, 7:48 am
Novartis Pharmaceuticals, a US subsidiary of a Swiss pharmaceutical group Novartis, settled with the US Department of Justice (DOJ) for $420 million for allegations of the off-label promotion of Trileptal, submitting false claims because of the unlawful marketing, and paying kickbacks to health care professionals inducing them to prescribe Trileptal and five other drugs. [read post]
1 Oct 2010, 5:35 am
Attorney Zane Memeger said Novartis Pharmaceuticals has agreed to pay a criminal fine and forfeiture of $185 million, and also agreed to pay $237.5 million to resolve civil liabilities for its off-label marketing of six drugs.U.K. [read post]
30 Sep 2010, 8:43 pm
Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million in two separate settlements resulting from their alleged off-label drug marketing. [read post]
30 Sep 2010, 5:03 am
Right on schedule to end the fiscal year, DOJ announced on September 30 that Novartis Pharmaceuticals Corp. has agreed to plead guilty to a misdemeanor and pay criminal and civil fines and damages. [read post]
27 Sep 2010, 12:59 am
Karst – Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
23 Sep 2010, 12:39 pm
Karst – On September 22, 2010, Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP)… [read post]
3 Sep 2010, 9:43 am
Some large corporations have a tendency to behave with ignorance when it comes to the internet. [read post]
25 Aug 2010, 7:37 am
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
